November Research Group Appoints Bio-Pharmaceutical Industry Executive, Shaun Naughton, MBA to the Position of Director of Marketing

Share Article

November Research Group announced the appointment of bio-pharmaceutical industry veteran, Shaun Naughton, MBA, as Director of Marketing.

November Research Group, LLC, (, a global leader of professional services, providing drug and medical device safety consulting and software solutions for pharmaceutical and life sciences organizations continues to attract top talent. The company announced the appointment of bio-pharmaceutical industry veteran, Shaun Naughton, MBA, as Director of Marketing.

"We are building a team that brings with it excellent cross-industry experience, professionalism, and 100 percent dedication to our clients' and partners' success. We will continue to seek out some of the best people in the industry who share in our vision to provide our customers with a rich experience of service and customer satisfaction, achieved through our sustained focus on pharmacovigilance," said Seth Warhaftig , President and CEO of November Research Group. "Shaun will spearhead our marketing program by combining his sales and marketing experience, business education and technology adoption to accelerate November’s commercialization efforts. I look forward to working with Shaun as we build new communication channels with our current and future customers and partners."

Shaun A. Naughton, Director of Marketing has more than 20 years experience with sales and marketing of scientific and medical data to biotech and pharmaceutical companies. Shaun has worked with several organizations focused on delivering, clinical and post marketing drug safety software and services including Phase Forward and Relsys Interational (Both acquired by Oracle’s Health Science Unit) as well as chemical and medical databases while working for Chemical Abstracts and Dialog. He holds B.A. in Biological Sciences and a M.B.A. from the University of San Diego.

About November Research Group

November Research Group is a professional services firm that provides a complete spectrum of software and services to the pharmacovigilance departments in the biopharmaceutical industry, with extensive expertise in: implementation and support for the Oracle Argus Safety Suite, Oracle AERS, and other commercial adverse event reporting systems; requirements specification and system selection; custom software application and tool development, and software validation. November Research Group is an Oracle PartnerNetwork (OPN) Gold Partner and is Specialized in Oracle Argus Safety Suite. In addition, November Research Group provides the PRIMO application for companies to enable a streamlined and rapid data intake for adverse event cases from all sources.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Susan A. Jalbert
Visit website